Diana Ferraro

Modena, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 139 publications

Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).

Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: July 04, 2026

A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.

A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: June 02, 2026

Quantitative MRI Uncovers Subtle Cortical Damage in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Quantitative MRI Uncovers Subtle Cortical Damage in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Journal: Annals of clinical and translational neurology

Published: March 08, 2026

Cardiogenic shock after ocrelizumab infusion in relapsing-remitting multiple sclerosis.

Cardiogenic shock after ocrelizumab infusion in relapsing-remitting multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: December 31, 2025

Translating neurofilament light chain testing into clinical practice: a multidisciplinary implementation roadmap.

Translating neurofilament light chain testing into clinical practice: a multidisciplinary implementation roadmap.

Journal: Clinical chemistry and laboratory medicine

Published: December 29, 2025

HerMeS: a registry-based evaluation of the HERCULES criteria for identifying nonrelapsing SPMS.

HerMeS: a registry-based evaluation of the HERCULES criteria for identifying nonrelapsing SPMS.

Journal: Journal of neurology

Published: December 05, 2025

Disability Worsening Phenotypes in Multiple Sclerosis and Impact of Disease-Modifying Treatments.

Disability Worsening Phenotypes in Multiple Sclerosis and Impact of Disease-Modifying Treatments.

Journal: Neurology

Published: November 24, 2025

Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MS.

Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MS.

Journal: JAMA network open

Published: November 03, 2025

Kappa Index predicts disease activity and transition to high-efficacy therapies in multiple sclerosis.

Kappa Index predicts disease activity and transition to high-efficacy therapies in multiple sclerosis.

Journal: Clinical chemistry and laboratory medicine

Published: October 12, 2025

Ofatumumab Versus Intravenous Ocrelizumab after Sphingosine-1-Phosphate Receptor Modulators in Patients with Relapsing-Remitting Multiple Sclerosis: A Real-World Inverse Probability of Treatment Weighting Multicenter Study.

Ofatumumab Versus Intravenous Ocrelizumab after Sphingosine-1-Phosphate Receptor Modulators in Patients with Relapsing-Remitting Multiple Sclerosis: A Real-World Inverse Probability of Treatment Weighting Multicenter Study.

Journal: CNS drugs

Published: September 28, 2025

Toward a Unified Definition of Progression Independent of Relapse Activity in Multiple Sclerosis.

Toward a Unified Definition of Progression Independent of Relapse Activity in Multiple Sclerosis.

Journal: Neurology

Published: September 22, 2025

Atypical clinical and MRI features in Leber hereditary optic neuropathy: a case series of four patients.

Atypical clinical and MRI features in Leber hereditary optic neuropathy: a case series of four patients.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: August 27, 2025

Showing 1-12 of 139

Last Updated: 09/26/2026